The Plan’s credibility rests on confronting its risks honestly. The matrix below sets out the principal risks, those inherent in a specialist-healthcare rollout and those surfaced by our own analysis, with the mitigations built into the strategy and financing.
|
Risk |
Assessment |
Mitigation |
|---|---|---|
|
Ophthalmologist recruitment shortfall |
High |
Competitive packages & equity; visiting surgeons; optometrist/nurse task-sharing; tele-ophthalmology; metros first, rural phased |
|
Slower-than-planned clinic ramp |
High |
Referral & medical-aid contracting from day one; conservative ramp; phased rollout; contingency & standby facility |
|
Early-year cash / negative DSCR |
High |
Principal grace period; debt-service reserve; equity-first drawdown; working-capital facility for medical-aid receivables |
|
NHI & medical-aid tariff / policy change |
Medium–High |
Diversified payer mix (private-pay, corporate, government); efficiency; engagement with reform |
|
Surgical-throughput below target |
Medium–High |
High-throughput theatres; visiting-surgeon rosters; scheduling discipline; conservative volume build |
|
Rollout delays & cost overruns |
Medium |
Phased build; fixed-price contracts; experienced project management; contingency |
|
Clinical / regulatory / safety |
Medium |
Central clinical governance; HPCSA compliance; credentialing & audit; malpractice cover |
|
Equipment cost / forex |
Medium |
Phased procurement; supplier financing; maintenance contracts |
Analyst flagThe three risks that most shape the investment
First, ophthalmologist supply, the binding constraint; if the clinics, especially the rural ones, cannot be staffed, the revenue does not materialise, and this risk sits above all others. Second, the ramp, how quickly each clinic fills, which is set by referral-network building and is inherently gradual and uncertain. Third, the early-year cash and debt-service position, with EBITDA negative in Year 1 and DSCR negative during the build, the financing must include a grace period, a reserve and a working-capital facility. None is disqualifying for an informed healthcare investor, but each is why the returns must be underwritten against the stress case and the staffing plan, not the base case alone.